Guest Content

Former Congressman Henry Waxman was recently interviewed for the Clause 8 podcast about how he worked together with Sen. Orrin […]

This paper was originally published by Bhaven N. Sampat and Kenneth C. Shadlen in PLoS ONE 13(4): e0194714 under a Creative

This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn,

This paper was originally published by Glenn P. Carroll, Sanjay Srivastava, Adam S. Volini, Marta M. Piñeiro-Núñez, and TatianaVetman in Drug Discovery

The World Health Organization’s (WHO) Essential Medicines List (EML) serves as a cornerstone in addressing this issue, providing a blueprint

The pharmaceutical industry faces unique challenges, from stringent regulatory requirements to high failure rates in drug development. This comprehensive guide

Pharmaceutical companies are constantly seeking innovative ways to combat this devastating disease. One promising avenue that has gained significant attention

Generic drugs play a crucial role in providing affordable medication options to patients worldwide. As we delve into the intricacies

This article was originally published by Ekaterina Galkina Cleary, Jennifer M. Beierlein, Navleen Surjit Khanuja, Laura M. McNamee and Fred D.